{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:39:09Z","timestamp":1791117549197,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2069,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>Although coffee consumption has been associated with reduced frequency of liver disease, it is unclear whether the effect is from coffee or caffeine and whether there is an effect on hepatic fibrosis specifically. This study was undertaken to use a food-frequency instrument for dietary caffeine consumption to evaluate the relationship between caffeine intake and liver fibrosis. Patients undergoing liver biopsy completed a detailed caffeine questionnaire on three occasions over a 6-month period. Caffeine intake was compared between patients with mild and advanced liver fibrosis (bridging fibrosis\/cirrhosis). Logistic regression was used to evaluate the association between caffeine consumption and hepatic fibrosis. One hundred seventy-seven patients (99 male, 104 white, 121 with chronic hepatitis C virus [HCV] infection) undergoing liver biopsy completed the caffeine questionnaire on up to three occasions. Results from repeated questionnaires were consistent. Daily caffeine consumption above the 75th percentile for the cohort (308 mg = approximately 2.25 cups of coffee equivalents) was associated with reduced liver fibrosis (odds ratio [OR], 0.33; 95% confidence interval [CI], 0.14-0.80;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.015) and the protective association persisted after controlling for age, sex, race, liver disease, body mass index, and alcohol intake in all patients (OR, 0.25; 95% CI, 0.09-0.67;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.006), as well as the subset with HCV infection (OR, 0.19; 95% CI, 0.05-0.66;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.009). Despite a modest trend, consumption of caffeine from sources other than coffee or of decaffeinated coffee was not associated with reduced liver fibrosis. A reliable tool for measurement of caffeine consumption demonstrated that caffeine consumption, particularly from regular coffee, above a threshold of approximately 2 coffee-cup equivalents per day, was associated with less severe hepatic fibrosis. (Hepatology 2010;51:201\u2013209.)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.23279","type":"journal-article","created":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T10:15:18Z","timestamp":1252491318000},"page":"201-209","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":249,"title":["Increased Caffeine Consumption Is Associated With Reduced Hepatic Fibrosis"],"prefix":"10.1097","volume":"51","author":[{"given":"Apurva A.","family":"Modi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Everhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake T.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Hoofnagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20241201","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/0003-4819-148-12-200806170-00003","article-title":"The relationship of coffee consumption with mortality.","volume":"148","author":"LopezGarcia","year":"2008","journal-title":"Ann Intern Med"},{"key":"R2-25-20241201","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.gastro.2004.09.075","article-title":"Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States.","volume":"128","author":"Ruhl","year":"2005","journal-title":"Gastroenterology"},{"key":"R3-25-20241201","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1053\/j.gastro.2005.08.056","article-title":"Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States.","volume":"129","author":"Ruhl","year":"2005","journal-title":"Gastroenterology"},{"key":"R4-25-20241201","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archinte.166.11.1190","article-title":"Coffee, cirrhosis, and transaminase enzymes.","volume":"166","author":"Klatsky","year":"2006","journal-title":"Arch Intern Med"},{"key":"R5-25-20241201","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ije\/27.3.438","article-title":"Coffee consumption and decreased serum gammaglutamyltransferase and aminotransferase activities among male alcohol drinkers.","volume":"27","author":"Tanaka","year":"1998","journal-title":"Int J Epidemiol"},{"key":"R6-25-20241201","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00146266","article-title":"Unexpected effects of coffee consumption on liver enzymes.","volume":"9","author":"Casiglia","year":"1993","journal-title":"Eur J Epidemiol"},{"key":"R7-25-20241201","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/oxfordjournals.aje.a117062","article-title":"Coffee and serum gammaglutamyltransferase: a study of selfdefense officials in Japan.","volume":"139","author":"Kono","year":"1994","journal-title":"Am J Epidemiol"},{"key":"R8-25-20241201","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1047-2797(99)00013-7","article-title":"Coffee drinking and serum gammaglutamyltransferase: an extended study of SelfDefense Officials of Japan.","volume":"9","author":"Honjo","year":"1999","journal-title":"Ann Epidemiol"},{"key":"R9-25-20241201","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0895-4356(01)00344-4","article-title":"Coffee consumption and serum aminotransferases in middleaged Japanese men.","volume":"54","author":"Honjo","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"R10-25-20241201","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S1047-2797(01)00223-X","article-title":"Coffee, caffeine, and the risk of liver cirrhosis.","volume":"11","author":"Corrao","year":"2001","journal-title":"Ann Epidemiol"},{"key":"R11-25-20241201","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1047-2797(02)00462-3","article-title":"Coffee intake and mortality from liver cirrhosis.","volume":"13","author":"Tverdal","year":"2003","journal-title":"Ann Epidemiol"},{"key":"R12-25-20241201","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2004.11.039","article-title":"Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a casecontrol study.","volume":"42","author":"Gelatti","year":"2005","journal-title":"J Hepatol"},{"key":"R13-25-20241201","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/dji040","article-title":"Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.","volume":"97","author":"Inoue","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R14-25-20241201","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ijc.20989","article-title":"Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan.","volume":"116","author":"Shimazu","year":"2005","journal-title":"Int J Cancer"},{"key":"R15-25-20241201","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/sj.bjc.6600582","article-title":"Does coffee protect against hepatocellular carcinoma?","volume":"87","author":"Gallus","year":"2002","journal-title":"Br J Cancer"},{"key":"R16-25-20241201","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.21708","article-title":"Coffee drinking and hepatocellular carcinoma risk: a metaanalysis.","volume":"46","author":"Bravi","year":"2007","journal-title":"Hepatology"},{"key":"R17-25-20241201","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1053\/j.gastro.2007.03.044","article-title":"Coffee consumption and risk of liver cancer: a metaanalysis.","volume":"132","author":"Larsson","year":"2007","journal-title":"Gastroenterology"},{"key":"R18-25-20241201","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis.","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"R19-25-20241201","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnci\/dji039","article-title":"Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer.","volume":"97","author":"Michels","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R20-25-20241201","doi-asserted-by":"crossref","first-page":"554","DOI":"10.7326\/0003-4819-144-8-200604180-00005","article-title":"The relationship between green tea and total caffeine intake and risk for selfreported type 2 diabetes among Japanese adults.","volume":"144","author":"Iso","year":"2006","journal-title":"Ann Intern Med"},{"key":"R22-25-20241201","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1079\/PHN2005752","article-title":"Green tea consumption in everyday life and mental health.","volume":"8","author":"Shimbo","year":"2005","journal-title":"Public Health Nutr"},{"key":"R23-25-20241201","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0278-6915(95)00093-3","article-title":"Caffeine consumption.","volume":"34","author":"Barone","year":"1996","journal-title":"Food Chem Toxicol"},{"key":"R25-25-20241201","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.taap.2007.09.018","article-title":"Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2: evidence that the coffeespecific diterpenes cafestol and kahweol confer protection against acrolein.","volume":"226","author":"Higgins","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"R26-25-20241201","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.fct.2007.09.094","article-title":"Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver.","volume":"46","author":"Huber","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"R27-25-20241201","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.fct.2007.09.099","article-title":"Induction of Nrf2mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver.","volume":"46","author":"Cavin","year":"2008","journal-title":"Food Chem Toxicol"},{"key":"R28-25-20241201","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.fct.2004.11.009","article-title":"Coffee diterpenes prevent the genotoxic effects of 2amino1methyl6phenylimidazo4,5bpyridine (PhIP) and Nnitrosodimethylamine in a human derived liver cell line (HepG2).","volume":"43","author":"Majer","year":"2005","journal-title":"Food Chem Toxicol"},{"key":"R29-25-20241201","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.fct.2007.05.010","article-title":"Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachlorideinduced liver damage in mice.","volume":"45","author":"Lee","year":"2007","journal-title":"Food Chem Toxicol"},{"key":"R30-25-20241201","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2008.03.029","article-title":"Pharmacological application of caffeine inhibits TGFbetastimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD23dependent pathways.","volume":"49","author":"Gressner","year":"2008","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23279","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201001000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:39:52Z","timestamp":1733042392000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201001000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23279","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2045956.1625054","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}